Cameron Coury, MD
Dermatology · Richardson, TXNPI 1104020767
Payments from drug & device makers
Across 445 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi$858
- Lilly USA, LLC$781
- Johnson & Johnson$699
- Arcutis Biotherapeutics, Inc.$644
- Amgen$483
- plus $4K from 27 others
What the payments were for
- Food & beverage$8,651100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $1,333 |
| Sanofi | 35 | $858 |
| Lilly USA, LLC | 34 | $781 |
| Johnson & Johnson | 28 | $699 |
| Arcutis Biotherapeutics, Inc. | 39 | $644 |
| Amgen | 19 | $483 |
| Sun Pharmaceutical Industries Inc. | 22 | $471 |
| Galderma Laboratories, L.p. | 32 | $470 |
| Regeneron Healthcare Solutions, Inc. | 19 | $470 |
| LEO Pharma Inc. | 13 | $305 |
| Dermavant Sciences, Inc. | 24 | $279 |
| Incyte Corporation | 20 | $274 |
| Pfizer | 15 | $266 |
| Novartis | 10 | $258 |
| Almirall LLC | 12 | $207 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $164 |
| Mayne Pharma Commercial LLC | 16 | $142 |
| UCB, Inc. | 4 | $78 |
| E.r. Squibb & Sons, L.L.C. | 4 | $73 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $59 |
| Dermira, Inc. | 3 | $43 |
| Organon | 3 | $42 |
| Journey Medical Corporation | 2 | $41 |
| Botanix SB Inc | 2 | $38 |
| VYNE Pharmaceuticals Inc. | 2 | $34 |
| Merck | 2 | $23 |
| EPI Health, LLC | 1 | $22 |
| Merz North America, Inc. | 1 | $20 |
| Springworks Therapeutics, Inc. | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $13 |
| DUSA Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$8,651 in reported general payments places this provider in the 60th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelaic Acid | 23 | $3,081 |
| Tacrolimus | 26 | $2,954 |
| Clobetasol Propionate | 88 | $2,556 |
| Fluorouracil | 35 | $2,186 |
| Doxycycline Hyclate | 58 | $1,367 |
| Triamcinolone Acetonide | 100 | $964 |
| Ketoconazole | 24 | $442 |
| Hydroxyzine Hcl | 17 | $417 |
| Fluticasone Propionate | 20 | $408 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $351 |
| Desonide | 12 | $323 |
| ValacyclovirValacyclovir Hcl | 15 | $135 |
| Minoxidil | 12 | $102 |
| Mupirocin | 23 | $41 |
| Prednisone | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Richardson
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
- Janet DuboisAustin$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.